Global Melioidosis Diagnostic Market Research Report 2022

Market Analysis and Insights: Global Melioidosis Diagnostic Market
Melioidosis, also called as Whitmore's Disease, is an infectious disease caused by the bacteria Burkholderia pseudomallei. Melioidosis infection usually affects the lungs and is diagnosed by blood, urine, saliva, or skin lesion examination. Melioidosis bacteria are present in polluted water and soil, and they propagate by direct contact with the contaminated source to humans and animals.
The global Melioidosis Diagnostic market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Bacterial culture test accounting for % of the Melioidosis Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Research laboratories segment is altered to an % CAGR throughout this forecast period.
China Melioidosis Diagnostic market size is valued at US$ million in 2021, while the North America and Europe Melioidosis Diagnostic are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Melioidosis Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melioidosis Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melioidosis Diagnostic market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melioidosis Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melioidosis Diagnostic market.
Global Melioidosis Diagnostic Scope and Market Size
Melioidosis Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Melioidosis Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Bacterial culture test
Latex fixation test
Hemagglutination assay
Immunofluorescence
Matrix-assisted laser desorption/ionization
Direct fluorescent antibody test
Other Tests

Segment by Application
Research laboratories
Hospitals
Academic institutions

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
PerkinElmer Inc.
InBios International, Inc.
Mediven
Cell Signaling Technology, Inc